Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04213248
What this trial is testing

Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD

Who this might be right for
Dry Eye
Zhongshan Ophthalmic Center, Sun Yat-sen University 27
Post-approval studies (Phase 4)Study completedNCT00832585
What this trial is testing

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Rush University Medical Center 5
Not applicableLooking for participantsNCT03148743
What this trial is testing

FMT in Gut aGVHD Treated

Who this might be right for
Acute-graft-versus-host Disease
The First Affiliated Hospital of Soochow University 50
Testing effectiveness (Phase 2)Study completedNCT00379587
What this trial is testing

Rituximab for Prevention of Chronic GVHD

Who this might be right for
Hematological Malignancies
Dana-Farber Cancer Institute 65
Large-scale testing (Phase 3)Study completedNCT00043147
What this trial is testing

Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)Study completedNCT01860183
What this trial is testing

Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

Who this might be right for
Kidney TransplantationKidney Failure
Clinical Hospital Merkur 76
Early research (Phase 1)Temporarily pausedNCT03467386
What this trial is testing

Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
City of Hope Medical Center 56
Not applicableLooking for participantsNCT03555851
What this trial is testing

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

Who this might be right for
Leukemia, Not Otherwise SpecifiedLeukemia, Other
Wake Forest University Health Sciences 120
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00006417
What this trial is testing

Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)UnknownNCT04688021
What this trial is testing

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Who this might be right for
LeukemiaGraft-versus-host-disease
Yi Luo 46
Not applicableEnrolling By InvitationNCT06864598
What this trial is testing

The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT

Who this might be right for
Graft-versus-host Disease (GVHD)
Peking University People's Hospital 100
Not applicableUnknownNCT01182792
What this trial is testing

Chronic Mountain Sickness, Systemic Vascular Function

Who this might be right for
Mountain SicknessChronic
University of Lausanne Hospitals 50
Not applicableStudy completedNCT06001398
What this trial is testing

Parent Acceptance and Commitment Therapy (PACT) for Parents of Children With Pediatric Feeding Disorder

Who this might be right for
Pediatric Feeding Disorder, ChronicPediatric Feeding Dysfunction, Acute
Children's Mercy Hospital Kansas City 30
Not applicableStudy completedNCT07271498
What this trial is testing

The Oral cGVHD as a Predictive Factor of Graft Versus Leukaemia Effect in Patients Who Received an Allograft

Who this might be right for
AllograftsOral cGVHD
Centre Hospitalier Universitaire de Nice 93
Not applicableActive Not RecruitingNCT04044365
What this trial is testing

Pediatric cGVHD Symptom Scale

Who this might be right for
Graft vs Host Disease
National Cancer Institute (NCI) 139
Not applicableLooking for participantsNCT06696300
What this trial is testing

Effects of Foundation and Functional Inspiratory Muscle Training in Non-Specific Chronic Low Back Pain

Who this might be right for
Low Back Pain, MechanicalLow Back Pain, ChronicNon Specific Chronic Low Back Pain
Kirsehir Ahi Evran Universitesi 60
Testing effectiveness (Phase 2)Looking for participantsNCT07012304
What this trial is testing

Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy

Who this might be right for
Chronic Graft Versus Host Disease
Yujun DONG 24
Testing effectiveness (Phase 2)Study completedNCT00201799
What this trial is testing

Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-Versus-Host Disease
Ohio State University Comprehensive Cancer Center 19
Next Page